TARRYTOWN, N.Y., March 9, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at Barclays Capital 2012 Global Healthcare Conference on Tuesday, March 13, 2012 at 3:45 p.m. Eastern Time. The March 13, 2012 date is a change from the previously announced date of March 14, 2012 and is due to conference rescheduling.
The session may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page. An archived version of the presentation will be available for thirty days after the live webcast.
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets two products in the United States, one for the treatment of neovascular (wet) age-related macular degeneration and another for the treatment of a rare inflammatory condition. Additionally, Regeneron has three regulatory applications pending before the U.S. Food and Drug Administration (FDA) and 10 drug candidates in clinical development. More information and recent news releases are available on the Regeneron web site at www.regeneron.com.
SOURCE Regeneron Pharmaceuticals, Inc.
